Andrea Lynema Ruetenik, a Neuroscience Ph.D.candidate at the University of Miami, Miller School of Medicine, was elected a 2018 Human Biology Project Fellow with the Huntington’s Disease Society of America.
Ruetenik’s proposal, “The protective role of NAD salvage pathway proteins against mutant huntingtin toxicity,” received funding for two year’s research.
“By funding important science from developing young scientists, HDSA’s Human Biology Project is actively shaping the scientific progress to treat and ultimately cure HD,” said Louise Vetter, president and chief executive officer of HDSA.
Ruetnik is a member of the Barrientos Lab, which focuses on the mechanisms that govern the biogenesis of mitochondrial protein complexes in health, disease and aging.
Neuroscience Graduate Program
University of Miami Miller School of Medicine